{"organizations": [], "uuid": "a820658c43f0cb0cc6a2387c4dc831bb13f45cb9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 2}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novartis-poaches-pfizer-oncology-h/brief-novartis-poaches-pfizer-oncology-head-elizabeth-barrett-idUSFWN1P511H", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis poaches Pfizer oncology head Elizabeth Barrett", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-11T08:08:00.000+02:00", "replies_count": 0, "uuid": "a820658c43f0cb0cc6a2387c4dc831bb13f45cb9"}, "author": "", "url": "https://www.reuters.com/article/brief-novartis-poaches-pfizer-oncology-h/brief-novartis-poaches-pfizer-oncology-head-elizabeth-barrett-idUSFWN1P511H", "ord_in_thread": 0, "title": "BRIEF-Novartis poaches Pfizer oncology head Elizabeth Barrett", "locations": [], "entities": {"persons": [{"name": "eliz", "sentiment": "negative"}, {"name": "elizabeth barrett", "sentiment": "negative"}, {"name": "elizabeth", "sentiment": "none"}, {"name": "bruno strigini", "sentiment": "none"}, {"name": "barrett", "sentiment": "none"}, {"name": "liz", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "pfizer", "sentiment": "negative"}, {"name": "barrett reuters staff", "sentiment": "none"}, {"name": "executive committee of novartis", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}, {"name": "pfizer, inc.", "sentiment": "none"}, {"name": "novartis oncology", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - Novartis says:\n* Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the Executive Committee of Novartis, effective February 1, 2018\n* Barrett succeeds Bruno Strigini who decided to retire from Novartis for personal reasons Further company coverage: (Reporting By Zurich newsroom)\n ", "external_links": [], "published": "2018-01-11T08:08:00.000+02:00", "crawled": "2018-01-11T08:22:19.009+02:00", "highlightTitle": ""}